DHAKA INSURANCE
============
FUNDAMENTAL DATA:
==============
CATEGORY: DA
FV: 100.00
ML: 50
NAV: 301.86
EPS: 90.88
EPS(2009): 57.57
EPS GROWTH: 57.86
NPAT: 136.32
NPAT(2009): 86.35
NPAT GROWTH: 57.87
LAST TRADE PRICE(10-02-2011): 2229.25
P/E: 24.53
PRICE/NAV: 7.39
ROE: 30.11
AUTHORISED CAPITAL: 200.00
PAID UP CAPITAL: 150.00
PUBLIC CAPITAL: 90.00
LDIV:YEND: 15% : 1209
RTAG: Q3
Comment:
Fundamental Strength:
MEDIUM
TECHNICAL ANALYSIS:
===============
Price and moving averages:
DHAKAINS has closed below its Short time moving average.
Short time moving average is currently below mid-time, AND above long time moving averages.
The relationship between price and moving averages is:
bearish in short-term, and neutral in mid-long term.
Bollinger Bands:
DHAKAINS has closed below the lower band by 1.4%. This combined with the steep downtrend can suggest that the downward trend in prices has a good chance of continuing. However, a short-term pull-back inside the bands is likely.
Bollinger Bands are 65.9% narrower than normal.
The narrow width of the bands suggests low volatility as compared to DHAKAINS's normal range. Therefore, the probability of volatility increasing with a sharp price move has increased for the near-term. The bands have been in this narrow range for 39 bars. The probability of a significant price move increases the longer the bands remain in this narrow range.
RSI
The current value for the RSI15 is 39.573
The RSI is not currently in a topping (above 70) or bottoming (below 30) range.
Failure Swings (also known as support or resistance penetrations or breakouts):The RSI does not currently show any Failure Swings.
Divergence:
The RSI and price are not diverging.
MACD
MACD Value: -39.655, Signal Line: -2.516
Crossovers:
Currently the MACD is bearish since it is trading below its signal line.
The MACD crossed below its signal line 38 period(s) ago.
Overbought/Oversold:
The MACD is not in an Overbought/Oversold range.
Divergence:
There have been no divergence signals within the last 5 periods.
CAUTION: This commentary is not a recommendation to buy or sell. Use at your own risk.